420 related articles for article (PubMed ID: 20522807)
1. Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo.
Yang J; Li X; Al-Lamki RS; Southwood M; Zhao J; Lever AM; Grimminger F; Schermuly RT; Morrell NW
Circ Res; 2010 Jul; 107(2):252-62. PubMed ID: 20522807
[TBL] [Abstract][Full Text] [Related]
2. Sildenafil potentiates bone morphogenetic protein signaling in pulmonary arterial smooth muscle cells and in experimental pulmonary hypertension.
Yang J; Li X; Al-Lamki RS; Wu C; Weiss A; Berk J; Schermuly RT; Morrell NW
Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):34-42. PubMed ID: 23139294
[TBL] [Abstract][Full Text] [Related]
3. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
[TBL] [Abstract][Full Text] [Related]
4. Id proteins are critical downstream effectors of BMP signaling in human pulmonary arterial smooth muscle cells.
Yang J; Li X; Li Y; Southwood M; Ye L; Long L; Al-Lamki RS; Morrell NW
Am J Physiol Lung Cell Mol Physiol; 2013 Aug; 305(4):L312-21. PubMed ID: 23771884
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated bone morphogenetic protein signaling in monocrotaline-induced pulmonary arterial hypertension.
Morty RE; Nejman B; Kwapiszewska G; Hecker M; Zakrzewicz A; Kouri FM; Peters DM; Dumitrascu R; Seeger W; Knaus P; Schermuly RT; Eickelberg O
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1072-8. PubMed ID: 17347486
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-β(1) represses bone morphogenetic protein-mediated Smad signaling in pulmonary artery smooth muscle cells via Smad3.
Upton PD; Davies RJ; Tajsic T; Morrell NW
Am J Respir Cell Mol Biol; 2013 Dec; 49(6):1135-45. PubMed ID: 23937428
[TBL] [Abstract][Full Text] [Related]
7. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.
Yang X; Long L; Southwood M; Rudarakanchana N; Upton PD; Jeffery TK; Atkinson C; Chen H; Trembath RC; Morrell NW
Circ Res; 2005 May; 96(10):1053-63. PubMed ID: 15845886
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of overactive transforming growth factor-β signaling by prostacyclin analogs in pulmonary arterial hypertension.
Ogo T; Chowdhury HM; Yang J; Long L; Li X; Torres Cleuren YN; Morrell NW; Schermuly RT; Trembath RC; Nasim MT
Am J Respir Cell Mol Biol; 2013 Jun; 48(6):733-41. PubMed ID: 23418342
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
[TBL] [Abstract][Full Text] [Related]
10. [Bone morphogenetic protein 4 increases canonical transient receptor potential protein expression by activating bone morphogenetic protein receptor Ⅱ/Smad signaling pathways in pulmonary arterial smooth muscle cells].
Li XY; Ran PX; Wang J
Zhonghua Jie He He Hu Xi Za Zhi; 2016 Jul; 39(7):539-45. PubMed ID: 27430926
[TBL] [Abstract][Full Text] [Related]
11. BMP type II receptor deficiency confers resistance to growth inhibition by TGF-β in pulmonary artery smooth muscle cells: role of proinflammatory cytokines.
Davies RJ; Holmes AM; Deighton J; Long L; Yang X; Barker L; Walker C; Budd DC; Upton PD; Morrell NW
Am J Physiol Lung Cell Mol Physiol; 2012 Mar; 302(6):L604-15. PubMed ID: 22227206
[TBL] [Abstract][Full Text] [Related]
12. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S
J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442
[TBL] [Abstract][Full Text] [Related]
13. Dynamin-related protein 1-mediated mitochondrial mitotic fission permits hyperproliferation of vascular smooth muscle cells and offers a novel therapeutic target in pulmonary hypertension.
Marsboom G; Toth PT; Ryan JJ; Hong Z; Wu X; Fang YH; Thenappan T; Piao L; Zhang HJ; Pogoriler J; Chen Y; Morrow E; Weir EK; Rehman J; Archer SL
Circ Res; 2012 May; 110(11):1484-97. PubMed ID: 22511751
[TBL] [Abstract][Full Text] [Related]
14. Activation of yes-associated protein mediates sphingosine-1-phosphate-induced proliferation and migration of pulmonary artery smooth muscle cells and its potential mechanisms.
Shi W; Wang Q; Wang J; Yan X; Feng W; Zhang Q; Zhai C; Chai L; Li S; Xie X; Li M
J Cell Physiol; 2021 Jun; 236(6):4694-4708. PubMed ID: 33283886
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of ID protein by growth and differentiation factor 5 (GDF5) through a smad-dependent and MAPK-independent pathway in HUVSMC.
Chen X; Zankl A; Niroomand F; Liu Z; Katus HA; Jahn L; Tiefenbacher C
J Mol Cell Cardiol; 2006 Jul; 41(1):26-33. PubMed ID: 16716349
[TBL] [Abstract][Full Text] [Related]
16. SphK1/S1P Mediates PDGF-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation via miR-21/BMPRII/Id1 Signaling Pathway.
Li F; Wang J; Zhu Y; Liu L; Feng W; Shi W; Wang Q; Zhang Q; Chai L; Li M
Cell Physiol Biochem; 2018; 51(1):487-500. PubMed ID: 30453304
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic protein signalling in heritable versus idiopathic pulmonary hypertension.
Dewachter L; Adnot S; Guignabert C; Tu L; Marcos E; Fadel E; Humbert M; Dartevelle P; Simonneau G; Naeije R; Eddahibi S
Eur Respir J; 2009 Nov; 34(5):1100-10. PubMed ID: 19324947
[TBL] [Abstract][Full Text] [Related]
18. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
Cheng G; Wang X; Li Y; He L
Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
[TBL] [Abstract][Full Text] [Related]
19. Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.
Maruyama H; Dewachter C; Belhaj A; Rondelet B; Sakai S; Remmelink M; Vachiery JL; Naeije R; Dewachter L
J Heart Lung Transplant; 2015 Mar; 34(3):468-78. PubMed ID: 25447587
[TBL] [Abstract][Full Text] [Related]
20. Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease.
Long L; Crosby A; Yang X; Southwood M; Upton PD; Kim DK; Morrell NW
Circulation; 2009 Feb; 119(4):566-76. PubMed ID: 19153267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]